Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A restricted ...

Please provide your email address to receive an email when new articles are posted on . The thiazolidinedione pioglitazone and GLP-1 receptor agonists are the only two diabetes drugs proved to ...